(lp0
S"Cytokinetics, Inc. Reports Fourth Quarter 2016 Financial Results GlobeNewswire  - Feb 16, 2017 16, 2017  -- Cytokinetics, Inc.  reported total revenues for the fourth quarter of 2016 were $33.1 million, compared to $9.8 million, during the same period in 2015.Cantor Fitzgerald Releases a Buy Rating on Cytokinetics Inc - Analyst RatingsCytokinetics'  CEO Robert Blum on Q4 2016 Results - Earnings Call Transcript - Seeking Alpha"
p1
aS"Why Cytokinetics, Inc. Got Hammered Today Motley Fool - Sep 1, 2016 Not mentioning an SPA doesn't mean that Amgen and Cytokinetics don't have one, although it would be a little weird to leave it out of the press release.Here's Why You Should Buy Cytokinetics, Inc.  As Amgen, Inc. (AMGN ... - TCCCytokinetics , Amgen  to Advance Omecamtiv Mecarbil to Phase 3 - StreetInsider.com"
p2
aS'Cytokinetics Inc. MarketWatch - Dec 21, 2009 Cytokinetics Inc. NASDAQ: CYTK. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p3
aS"Form 8-K CYTOKINETICS INC For: Mar 23 StreetInsider.com - Mar 23, 2017 Cytokinetics, Inc. and Origent Data Sciences, Inc.  announced the advancement of their research collaboration to prospectively validate Origent's computer model to predict the course of ALS  disease progression ..."
p4
aS"JMP Securities Bullish on Cytokinetics, Inc.  Following 2Q Update; Sees ... Smarter Analyst - Aug 1, 2016 In light of Cytokinetics, Inc.'s  second-quarter update, JMP Securities analyst Jason Butler remains bullish for the biotech company's pipeline drug-paved road ahead."
p5
aS'Cytokinetics Announces Preclinical Data for CK-2127107 Presented at MDA ... GlobeNewswire  - Mar 22, 2017 SOUTH SAN FRANCISCO, Calif., March 22, 2017  -- Cytokinetics, Inc.  today announced that preclinical data for CK-2127107 were presented at the MDA Scientific Conference in Arlington, VA, showing that this&nbsp;...'
p6
aS'Cytokinetics Announces Additional Results From COSMIC-HF Presented at ACC.17 GlobeNewswire  - Mar 20, 2017 SOUTH SAN FRANCISCO, Calif., March 20, 2017  -- Cytokinetics, Inc.  today announced that additional results from COSMIC-HF , a Phase&nbsp;...'
p7
aS"Cytokinetics and Astellas Announce Option Right for Tirasemtiv and Expansion ... GlobeNewswire  - Jul 27, 2016 SOUTH SAN FRANCISCO, Calif. and TOKYO, July 27, 2016  -- Cytokinetics, Inc.   and Astellas Pharma Inc.   today announced that Cytokinetics and Astellas have expanded their&nbsp;...With latest swing, Peninsula biotech tries to double up Lou Gehrig's disease - San Francisco Business Times Cytokinetics Gets $95M in First ALS Deal, Needs Results For More - Xconomy"
p8
aS"Cytokinetics, Inc.  Shares Sold by Tudor Investment Corp Et Al The Cerbat Gem - Mar 27, 2017 Cytokinetics logo Tudor Investment Corp Et Al cut its stake in Cytokinetics, Inc.  by 58.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC.Cytokinetics, Inc.  Now Covered by Rodman &amp; Renshaw - Sports PerspectivesCytokinetics'  Buy Rating Reiterated at Rodman &amp; Renshaw - Community Financial News"
p9
aS'Cytokinetics Announces Start of GALACTIC-HF, a Phase 3 Clinical Trial of ... GlobeNewswire  - Dec 1, 2016 SOUTH SAN FRANCISCO, Calif., Dec. 01, 2016  -- Cytokinetics, Inc.  today announced the activation of the first clinical site and the start of GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes&nbsp;...Amgen, Cytokinetics Launch Heart Study  - InvestopediaCytokinetics earns $26.7M milestone from Amgen on start of large-scale CV ... - Seeking Alpha'
p10
a.